PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Dr Reddy's Laboratories (UK) Ltd
DR

Dr Reddy's Laboratories (UK) Ltd

Cambridge
Large

Dr. Reddy's Laboratories (UK) Ltd is a multinational pharmaceutical company focused on accelerating access to affordable and innovative medicines. They manage the entire supply chain from production to distribution, ensuring their medicines are available to patients in need.

drreddys.uk ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£1.2bn
Live
71
Buyers
9
12m
£947.8m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities2
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts71 / 96
  • Top buyers9
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Dr Reddy's Laboratories (UK) LtdUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Dr Reddy's Laboratories (UK) Ltd has won £1.2bn across 9 public-sector buyers, with 71 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 95% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
71 of 96Live contracts
95%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 1/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
Environment1 commitment ↗✓
Tackling inequalityNo commitment stated✓
CommunityNo commitment stated✓
Environment · 1
  • WebsiteBusiness responsibility and sustainabilityCommitment to human rights, ethics, health and safety, and environmental management.

Extracted automatically from drreddys.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 3
API ManufacturingManufacturing of Active Pharmaceutical Ingredients. ↗R&DResearch and Development for innovative medicines. ↗Medicines PortfolioAffordable prescription and OTC medicines. ↗
Frameworks & DPS · 2 from notices
  • NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England · £13.3m
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k

Extracted automatically from drreddys.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships · 2

Credentials listed on the supplier’s website. Not yet checked against issuer registers.

◐ From supplier website
Core credentials · 0/6
Cyber EssentialsNot evidenced✓
Cyber Essentials PlusNot evidenced✓
ISO 27001 — Information securityNot evidenced✓
ISO 9001 — QualityNot evidenced✓
ISO 14001 — EnvironmentalNot evidenced✓
ISO 45001 — Health & safetyNot evidenced✓
Other credentials & memberships · 2
Pharmaceutical Supply Chain Initiativemembership
Dow Jones Sustainability Indicesaward

Extracted automatically from drreddys.uk on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 71 live · 25 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026
NHS England—01 Sept 2026£813.9m2 yrspending
NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
NHS England—01 May 2026£14.8m17 mopending
Transitional Drugs 6
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)—01 Mar 2026£1.6m2 yrspending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£17.7m12 mopending
NHS National Transition Framework for Apremilast, Pazopanib and Dapagliflozin
NHS England—01 Feb 2026£25.9m1.7 yrspending
NHS National Framework for Generics Housekeeping
NHS England—01 Feb 2026£21.6m1.7 yrspending
NHS National Framework for Transition products (Axitinib and Eltrombopag)
NHS England—01 Oct 2025£52.4m16 mopending
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
NHS England3360000001 Sept 2025£47.0m2 yrsLive
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National
NHS England3360000001 Sept 2025£9.4m2 yrsLive
NHS National Framework for Transition products (Nilotinib and Ticagrelor)
NHS England North East and Yorkshire Health and Justice—01 Sept 2025£22.1m17 mopending
Total live value £135.7m · mean award £12.5m1–10 of 96

Top buyers · 9 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
54 contracts
95%
since 2021
2
NHS England North East and Yorkshire Health and Justice
2 contracts
4%
since 2025
3
NHSE&I
1 contract
1%
since 2022
4
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
2 contracts
0%
since 2026
5
NHS England and NHS Improvement
1 contract
0%
since 2022
6
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
6 contracts
0%
7
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
22 contracts
0%
8
The NHS Commissioning Board (operating under the name of NHS England)
7 contracts
0%
9
eTenderwales
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire57 contracts
100%
Wales9 contracts
0%
Scotland22 contracts
0%
North West7 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Dr Reddy's Laboratories (UK) Ltd highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
DR
Dr Reddy's Laboratories (UK) Ltd
No£947.8m—
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
PF
Pfizer Ltd
Yes£69.8m25
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Mar 2025
Confirmation statement
Due in -57d
Next due 14 May 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
01729064
Status
Active
Type
Private limited
Incorporated
03 Jun 1983
Reg. office
410 Cambridge Science Park Milton Road, Cambridge, CB4 0PE
SIC codes
21200
Last accounts
31 Mar 2025
Next accounts due
31 Dec 2026

Directors & PSC

  • KUMAR, Manoj — director
    Appointed 30 Apr 2025
  • OBERTE, Kristine — director
    Appointed 30 Apr 2024
  • BAHETI, Anup Kumar — secretary
    Appointed 17 May 2022
  • YASSAR, Mohammed — director
    Appointed 06 May 2021
  • AGHANIAN, Patrick — director
    Appointed 04 Mar 2020
  • MANNAM, Venkata Narsimham — director
    Appointed 03 May 2010
  • Dr Reddys Laboratories (Eu) Ltd — person with significant control
    ownership of shares 75 to 100 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
DR REDDY'S LABORATORIES (UK) LIMITED
01729064 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.